ReWalk Robotics Ltd. logo
ReWalk Robotics Ltd. RWLK
report update icon

Quarterly report 2026-Q1
added 05-20-2026

ReWalk Robotics Ltd. Income Statement 2025-2011 | RWLK

Brief overview of income trends at ReWalk Robotics Ltd.

The overview follows changes across a five-year period. ReWalk Robotics Ltd. reported revenue of $4.4 million in 2020 and $22 million by 2025. Overall revenue changed by +401.6%, equal to an annualized rate of about 38.1%. This pace points to rapid expansion of the business.

Gross profit was 2.2 million dollars at the start and 8.4 million dollars at the end of the period (+285%). The relationship between sales and direct costs deteriorated. Gross profit as a share of revenue changed from 49.8% to 38.2%. The business retained less gross profit from each unit of revenue.

Over the period, EBITDA shifted from −$11.7 million to −$19.3 million, a change of −65%. Operating performance weakened relative to revenue. The EBITDA share of revenue changed from −266.8% to −87.8%. Higher profitability strengthens the quality of operating growth.

Comparing the endpoints shows a move from −13 million dollars to −19.9 million dollars. Larger losses indicate rising pressure on the business.

Financial takeaway

The results contain several connected negative signals. The strongest signals are a larger revenue base and positive operating leverage. The overall view is constrained by a lower gross margin, a low EBITDA margin and a weaker final result. The key question is whether sales can be converted into sustainable profit.

Annual Income Statement ReWalk Robotics Ltd.

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

- 768 K 754 K 6.77 M 50.3 M 41.8 M 11.3 M 10.7 M 21.2 M 28.3 M 125 M 65.7 M - - -

Shares

1.16 M 724 K 711 K 8.91 M 47.9 M 15.8 M 5.76 M 1.47 M 809 K 527 K 485 K 151 K - - -

Historical Prices

- 1.06 1.06 0.76 1.05 2.65 0.734 6.33 30.6 57.5 262 429 - - -

Net Income

-19.9 M -28.9 M -22.1 M -19.6 M -12.7 M -13 M -15.6 M -21.7 M -24.7 M -32.5 M -25.4 M -21.7 M -12.2 M -6.66 M -

Revenue

22 M 25.7 M 13.9 M 5.51 M 5.97 M 4.39 M 4.87 M 6.54 M 7.75 M 5.87 M 3.75 M 3.95 M 1.59 M 972 K -

Cost of Revenue

13.6 M 17.4 M 9.4 M 3.61 M 3.06 M 2.2 M 2.15 M 3.72 M 4.65 M 5.13 M 3.53 M 4.11 M 2.02 M 983 K -

Gross Profit

8.43 M 8.22 M 4.45 M 1.9 M 2.9 M 2.19 M 2.73 M 2.82 M 3.1 M 736 K 214 K -621 K -429 K -11 K -

Operating Income

-19.7 M -29.3 M -23.6 M -19.1 M -12.7 M -12 M -14 M -19.2 M -22 M -30.4 M -25.2 M -19.9 M -8.74 M -5.76 M -

Interest Expense

-312 K 643 K 1.35 M - - - - - - - - - - - -

EBITDA

-19.3 M -28.9 M -23.4 M -18.9 M -12.4 M -11.7 M -13.7 M -18.8 M -21.4 M -29.7 M -24.7 M -19.3 M -8.65 M -5.7 M -

Operating Expenses

28.1 M 37.6 M 28.1 M 21 M 15.6 M 14.2 M 16.8 M 22 M 25.1 M 31.2 M 25.4 M 19.3 M 8.32 M 5.75 M -

General and Administrative Expenses

8.2 M 5.2 M 10 M 7.13 M 5.63 M 4.98 M 5.26 M 6.79 M 7.69 M 8.19 M 6.4 M 3.35 M 1.76 M 1.66 M -

All numbers in USD currency

Quarterly Income Statement ReWalk Robotics Ltd.

2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

1.61 M 16 M 11.2 M 10.5 M 8.81 M 8.76 M 8.61 M 8.59 M 8.59 M 8.54 M 8.5 M 8.5 M 60.1 M 62.8 M 62.5 M 62.5 M 62.5 M 46.6 M 46.1 M 36.2 M 25.3 M 18.9 M 13.1 M 10.4 M 7.32 M 7.29 M 5.21 M 3.21 M 2.81 M 1.42 M 1.31 M 1.2 M 30 M 21.7 M 17.2 M 16.5 M 16.3 M 12.8 M 12.4 M 12.3 M 12.2 M 12.1 M 12.1 M 12 M 12 M - - - 186 K - - - - - - - - - - -

Net Income

-10.8 M -3.17 M -6.56 M -4.83 M - -3.08 M -4.3 M -6.28 M - -7.53 M -4.64 M -4.32 M - -5.46 M -4.45 M -4.35 M - -2.68 M -3.14 M -3.06 M - -3.34 M -2.86 M -3.84 M - -3.39 M -4.59 M -4 M - -4.53 M -5.8 M -6.33 M - -24.7 M -24.7 M -24.7 M - -32.5 M -32.5 M -32.5 M - -25.4 M -25.4 M -25.4 M - - - - - - - - - - - - - - - -

Revenue

3.92 M 6.2 M 5.72 M 5.03 M - 6.13 M 6.71 M 5.28 M - 4.4 M 1.34 M 1.23 M - 886 K 1.57 M 876 K - 1.97 M 1.44 M 1.32 M - 747 K 1.67 M 760 K - 1.23 M 877 K 1.58 M - 1.62 M 1.77 M 1.58 M - 1.73 M 2.01 M 2.5 M - 1.4 M 817 K 2.06 M - 1.16 M 610 K 635 K - - - - - - - - - - - - - - - -

Cost of Revenue

2.58 M 3.49 M 3.21 M 2.91 M - 3.91 M 3.95 M 3.89 M - 3.54 M 761 K 659 K - 665 K 824 K 611 K - 832 K 709 K 609 K - 355 K 646 K 387 K - 585 K 442 K 655 K - 855 K 1 M 897 K - 1.02 M 1.27 M 1.45 M - 1.11 M 732 K 1.57 M - 1.08 M 550 K 602 K - - - - - - - - - - - - - - - -

Gross Profit

1.34 M 2.71 M 2.51 M 2.12 M - 2.22 M 2.76 M 1.4 M - 863 K 576 K 571 K - 221 K 746 K 265 K - 1.14 M 727 K 707 K - 392 K 1.02 M 373 K - 649 K 435 K 926 K - 762 K 767 K 682 K - 708 K 741 K 1.05 M - 290 K 85 K 493 K - 87 K 60 K 33 K - - - - - - - - - - - - - - - -

Operating Income

-10.3 M -3.14 M -6.56 M -4.85 M - -3.17 M -4.44 M -6.5 M - -7.94 M -5.16 M -4.38 M - -5.43 M -4.38 M -4.29 M - -2.66 M -3.14 M -3.02 M - -3.07 M -2.55 M -3.6 M - -3.03 M -4.24 M -3.58 M - -4.12 M -5.28 M -5.84 M - -5.35 M -5.37 M -5.66 M - -7.4 M -8.59 M -6.42 M - -6.3 M -5.84 M -5.52 M - - - - - - - - - - - - - - - -

Interest Expense

416 K - - - - - - 8 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

-10.3 M - - -4.76 M - - - -6.38 M - - - -4.34 M - -5.27 M -4.27 M -4.24 M - -2.45 M -3 M -2.95 M - -2.85 M -2.4 M -3.53 M - -2.79 M -4.06 M -3.48 M - -3.77 M -5.05 M -5.73 M - -4.84 M -5.01 M -5.48 M - -6.9 M -8.26 M -6.25 M - -6.06 M -5.72 M -5.48 M - - - - - - - - - - - - - - - -

Operating Expenses

11.7 M 5.85 M 9.07 M 6.98 M - 5.39 M 7.2 M 7.9 M - 8.8 M 5.73 M 4.95 M - 5.65 M 5.12 M 4.55 M - 3.8 M 3.87 M 3.73 M - 3.46 M 3.57 M 3.98 M - 3.68 M 4.67 M 4.5 M - 4.88 M 6.04 M 6.52 M - 6.06 M 6.11 M 6.7 M - 7.69 M 8.67 M 6.91 M - 6.39 M 5.9 M 5.55 M - - - - - - - - - - - - - - - -

General and Administrative Expenses

2.56 M 1.96 M 1.74 M 2.22 M - 240 K 1.59 M 1.59 M - 3.46 M 2.41 M 1.71 M - 2 M 1.82 M 1.46 M - 1.34 M 1.44 M 1.26 M - 1.2 M 1.27 M 1.31 M - 1.21 M 1.28 M 1.5 M - 1.36 M 2.22 M 2.04 M - 1.8 M 1.85 M 2.14 M - 1.95 M 2.1 M 1.91 M - 1.52 M 1.46 M 1.5 M - - - - - - - - - - - - - - - -

All numbers in USD currency

The income statement is one of the three key financial reports of a company ReWalk Robotics Ltd. (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:

  • How much revenue the company earned
  • How much it spent on production, personnel, marketing, taxes, etc.
  • What profit remained in the end

Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.

Features
  • The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
  • Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
  • A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.

Reports on the profits and losses of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
GBS GBS
GBS
- -0.57 % $ 7.12 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 57.08 3.84 % $ 8.66 B usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
- - $ 162 M franceFrance
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 15.55 0.18 % $ 440 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
$ 8.8 6.24 % $ 642 M israelIsrael
Electromed Electromed
ELMD
$ 29.6 0.27 % $ 245 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 0.71 0.69 % $ 12 M usaUSA
LivaNova PLC LivaNova PLC
LIVN
$ 80.32 0.36 % $ 4.38 B britainBritain
LENSAR LENSAR
LNSR
$ 8.3 0.24 % $ 99.3 M usaUSA
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.34 0.15 % $ 21.2 M usaUSA
SmileDirectClub SmileDirectClub
SDC
- -53.45 % $ 9.71 M usaUSA
Sientra Sientra
SIEN
- -16.59 % $ 10.3 M usaUSA
Silk Road Medical, Inc Silk Road Medical, Inc
SILK
- - $ 1.07 B usaUSA
NanoVibronix NanoVibronix
NAOV
- - $ 1.08 M usaUSA
Surgalign Holdings Surgalign Holdings
SRGA
- -32.98 % $ 1.68 M usaUSA
ShockWave Medical ShockWave Medical
SWAV
- - $ 12.3 B usaUSA
NuVasive NuVasive
NUVA
- - $ 2.07 B usaUSA
Natus Medical Incorporated Natus Medical Incorporated
NTUS
- 1.94 % $ 1.05 B usaUSA
Nevro Corp. Nevro Corp.
NVRO
- - $ 217 M usaUSA
ThermoGenesis Holdings ThermoGenesis Holdings
THMO
- -25.84 % $ 171 K usaUSA
Talis Biomedical Corporation Talis Biomedical Corporation
TLIS
- 3.55 % $ 7.96 M usaUSA
Titan Medical Titan Medical
TMDI
- -26.32 % $ 19.6 M canadaCanada
Butterfly Network Butterfly Network
BFLY
$ 8.43 0.93 % $ 2.08 B usaUSA
Vapotherm Vapotherm
VAPO
- 6.72 % $ 34 M usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 125.33 0.02 % $ 4.35 B usaUSA